Ticker Details
MaxCyte, Inc. Common Stock
IPO Date:	July 26, 2021
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$142.42M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.17 | 3.60%
Avg Daily Range (30 D):	$0.06 | 4.82%
Avg Daily Range (90 D):	$0.05 | 4.28%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	.9M
Avg Daily Volume (90 D):	.92M

Trade Size
Avg Trade Size (Sh.):	122
Avg Trade Size (Sh.) (30 D):	193
Avg Trade Size (Sh.) (90 D):	138

Institutional Trades
Total Institutional Trades:	173
Avg Institutional Trade:	$2.38M
Avg Institutional Trade (30 D):	$4.63M
Avg Institutional Trade (90 D):	$3.68M
Avg Institutional Trade Volume:	.46M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.2M
Avg Closing Trade (30 D):	$12.22M
Avg Closing Trade (90 D):	$6.51M
Avg Closing Volume:	715.96K

News

May 13, 2026 @ 12:52 PM Stock Market Today: Dow Jones Futures Fall, Nasdaq... Source: Rishabh Mishra

Jan 12, 2026 @ 1:05 PM MaxCyte Announces Preliminary Unaudited Fourth Qua... Source: Globe Newswire

Jul 4, 2024 @ 1:11 PM Global Transfection Technologies Market Predicted ... Source: Polaris Market Research (Pmr)

Jun 13, 2024 @ 1:55 PM Does MaxCyte (MXCT) Have the Potential to Rally 85... Source: Zacks Equity Research

Jun 13, 2024 @ 12:50 PM Recent Price Trend in MaxCyte (MXCT) is Your Frien... Source: Zacks Equity Research

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.34	$-.08	$-.04
Diluted EPS	$-.34	$-.08	$-.04
Revenue	$31.05M	$7.27M	$9.65M
Gross Profit	$24.6M	$5.6M	$8.08M
Net Income / Loss	$-35.64M	$-8.87M	$-4.75M
Operating Income / Loss	$-41.79M	$-10.23M	$-6.19M
Cost of Revenue	$6.45M	$1.68M	$1.57M
Net Cash Flow	$-.18M	$.49M	$-5.51M
PE Ratio